Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin-Reference-Cited by-同舟云学术

Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin

Published:2016-01 Issue:1 Volume:64 Page:29-36
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Younossi Zobair M.,Stepanova Maria,Estep Michael,Negro Francesco,Clark Paul J.,Hunt Sharon,Song Qinghua,Paulson Matthew,Stamm Luisa M.,Brainard Diana M.,Subramanian G. Mani,McHutchison John G.,Patel Keyur

Publisher

Elsevier BV

Subject

Hepatology

Reference54 articles.

1. Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus;Ye;PLoS Pathog,2007

2. Hepatitis C virus hijacks host lipid metabolism;Syed;Trends Endocrinol Metab,2010

3. Role of lipid metabolism in hepatitis C virus assembly and entry;Popescu;Biol Cell,2010

4. Lipid metabolism and HCV infection;Targett-Adams;Viruses,2010

5. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion;Gastaminza;J Virol,2008

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in the Lipid Asset of HIV/HCV Patients after a Successful Course of Direct-Acting Antivirals;Journal of Clinical Medicine;2024-06-30

2. Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review;Liver International;2024-02-22

3. Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol;Scientific Reports;2022-06-15

4. Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis;Scientific Reports;2022-04-01

5. Monitoring of iron, lipid and liver profiles in Egyptian hepatitis C virus patients on sofosbuvir therapy;Journal of Infection and Public Health;2022-03